Status quo of symptom clusters in patients with cervical cancer undergoing concurrent chemoradiotherapy and its influencing factors
10.3760/cma.j.cn115682-20230329-01227
- VernacularTitle:宫颈癌同步放化疗患者症状群及影响因素研究
- Author:
Hao TIE
1
;
Lirong LI
;
Limei SHI
;
Xinyu HAO
Author Information
1. 广西医学科学院 广西壮族自治区人民医院肿瘤中心放疗一病区，南宁 530021
- Keywords:
Uterine cervical neoplasms;
Chemoradiotherapy;
Syndrome;
Influencing factors
- From:
Chinese Journal of Modern Nursing
2023;29(33):4601-4607
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To explore the symptoms in cervical cancer patients during concurrent chemoradiotherapy, identify symptom clusters, and analyze their influencing factors, so as to provide reference for developing precise symptom management strategies.Methods:From March 2022 to March 2023, convenience sampling was used to select 240 cervical cancer patients who underwent concurrent chemoradiotherapy at the Cancer Center of People's Hospital of Guangxi Zhuang Autonomous Region as the research subject. Patients were surveyed using a General Information Questionnaire and the Chinese version of the M.D. Anderson Symptom Inventory (MDASI-C). Symptom clusters were extracted through exploratory factor analysis, and multiple linear regression was used to explore the influencing factors of the severity of symptom clusters.Results:A total of 240 questionnaires were distributed, and 234 valid questionnaires were collected, with an effective recovery rate of 97.50% (234/240). The 5 symptoms with a high incidence in 234 patients with cervical cancer undergoing concurrent chemoradiotherapy were fatigue, restless sleep, nausea, decreased appetite, and vomiting. The 4 symptom clusters identified by exploratory factor analysis were fatigue related symptom cluster, gastrointestinal related symptom cluster, emotional related symptom cluster, and somatic related symptom cluster. Age, educational level, tumor staging, complications, medical insurance type, and pathological type were the influencing factors for the occurrence of symptom clusters ( P<0.05) . Conclusions:Cervical cancer patients experience multiple symptoms during concurrent chemoradiotherapy, which are interrelated and mutually influencing, often in the form of symptom clusters, with fatigue related symptom clusters being severe. Medical and nursing staff should focus on the core symptoms that play a leading role, develop targeted symptom cluster intervention plans based on the core symptoms of fatigue, improve symptom management efficiency and patient quality of life.
